Clinical trials
Anemia clinical trials
Below are recruiting anemia clinical trials, each written for real people, not researchers. We’re tracking 258 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06601283RecruitingPhase 2/Phase 3
Vitamin C and Cordyceps for Anemia in Pancreatic Cancer
This trial tests whether adding vitamin C and a fungus called cordyceps to standard chemotherapy can help improve anemia (low red blood cells) in people with advanced pancreatic cancer. It's for those who have not yet had treatment for their cancer.
ShanghaiAges 18–80 - NCT07586735Recruiting
A new preparative regimen for stem cell transplant in older patients with severe aplastic anemia
This study tests a new combination of drugs to prepare older patients (40–60 years old) with severe aplastic anemia for a stem cell transplant from a half-matched donor. The goal is to make the transplant safer and more effective for this age group.
Beijing, Beijing MunicipalityAges 40–60 - NCT07577817RecruitingEarly Phase 1
Safety Study of CTX001 in Healthy Adults
This early-stage study tests a new experimental drug called CTX001 in healthy volunteers to check if it is safe and well-tolerated. Researchers will also measure how your body processes the drug and how it affects certain blood markers.
Melbourne, VictoriaAges 18–55 - NCT07566494RecruitingPhase 1
Testing VAS-101 for sickle cell disease
This early-phase trial tests a new drug called VAS-101 for people with sickle cell disease. It aims to find a safe dose and see how the drug affects the body.
Bethesda, MarylandAges 18–90 - NCT06733610RecruitingPhase 1
CAR T-cell therapy for AIHA after 3 failed treatments
This trial tests a new type of immunotherapy called CAR T-cell therapy that targets two markers on your immune cells (CD19 and BCMA). It is for people with autoimmune hemolytic anemia (AIHA) who have already tried at least 3 standard treatments without success.
Tianjin, Tianjin MunicipalityAges 18 years+ - NCT07527975Enrolling by invitation
Long-term safety and benefit check-up for RP-L102 gene therapy
This is a follow-up study for patients who previously received RP-L102, an experimental gene therapy designed to treat Fanconi anemia by fixing a faulty gene. The study tracks how well the treatment continues to work and watches for any long-term side effects.
Palo Alto, CaliforniaAges Any age - NCT07499284Recruiting
Haplo-Cord Stem Cell Transplant for Aplastic Anemia
This trial tests a new way of using a mix of donor stem cells (from a half-matched family member and a cord blood unit) to treat aplastic anemia, a condition where the bone marrow stops making enough blood cells. The goal is to see if this transplant approach is safe and helps rebuild healthy blood cells.
Suzhou, JiangsuAges 14 years+ - NCT05353348Recruiting
Program to treat mild anemia around heart surgery
This trial tests a combined treatment plan to improve anemia (low blood count/iron levels) before and around the time of major elective heart surgery. It may help reduce the need for blood transfusions and support safer recovery.
Hangzhou, ZhejiangAges 18 years+ - NCT07461116Recruiting
Side effects of ATG/ALG treatment for aplastic anemia
This study looks at the side effects of a medicine called ATG or ALG, which is given to calm the immune system in people with aplastic anemia. It may help doctors better understand and manage these side effects.
TianjinAges Any age - NCT07460518RecruitingPhase 4
Tranexamic acid for reducing bleeding during prostate surgery
This trial tests whether a medicine called tranexamic acid, given during surgery to remove part of the prostate, can reduce bleeding. If you are scheduled for this type of prostate surgery, this treatment might help make the procedure safer and improve recovery.
RabatAges 50 years+ - NCT07453368RecruitingPhase 2
Orelabrutinib for relapsed or hard-to-treat AIHA
This trial tests a targeted pill called orelabrutinib for people with autoimmune hemolytic anemia (AIHA) that has come back or not responded to standard treatments. It may help control your immune system's attack on your red blood cells.
Beijing, Beijing MunicipalityAges 18–85 - NCT07441525RecruitingEarly Phase 1
CAR-T cell therapy for hard-to-treat autoimmune blood diseases
This early-stage trial tests a new type of immune cell therapy (CAR-T) that targets two proteins, CD19 and BCMA, in people with autoimmune blood diseases like ITP, AIHA, or Evans syndrome that have not responded to standard treatments. It aims to reset the immune system and reduce production of harmful antibodies.
Wuhan, HubeiAges 18–75 - NCT07400796Recruiting
Prenatal vitamin study for pregnant women in Cambodia
This study looks at giving multiple micronutrient supplements (MMS) to pregnant women in Takeo, Cambodia. It aims to understand how well the health system can provide these vitamins instead of the usual iron and folic acid.
Phnom PenhAges 18 years+ - NCT07400341RecruitingPhase 2
Romiplostim vs rhTPO for platelet recovery after transplant
This trial compares two drugs, romiplostim and rhTPO, to help increase platelet counts after a stem cell transplant in people with MDS or aplastic anemia. The goal is to see which drug works better at reducing the need for platelet transfusions.
Suzhou, JiangsuAges 18–65 - NCT07394972Recruiting
Iron absorption from lactoferrin in women with low iron
This trial tests whether a stabilized form of lactoferrin (a protein naturally found in milk) can help women with low iron stores absorb iron better. You may qualify if you have low iron but are not anemic, have a normal weight, and follow a few other health guidelines.
ZurichAges 18–45 - NCT07394088Recruiting
AI tool for iron deficiency in adults
This trial tests if an AI system can help doctors better identify iron deficiency by analyzing routine blood test results. It may help find patients who need extra treatment.
TaichungAges 18 years+ - NCT05755867Recruiting
Global registry for people with paroxysmal nocturnal hemoglobinuria
This trial is a global patient registry that collects health information from people diagnosed with PNH (a blood condition caused by a genetic change in the PIG-A gene). It may help researchers better understand the condition and what care people receive.
Bethesda, MarylandAges Any age - NCT06146608Recruiting
Iron, gut bacteria, and how the body absorbs iron
This study looks at how different types of iron in food affect your gut bacteria and how well your body absorbs iron. It aims to understand the connection between diet, gut health, and iron levels in healthy adults.
Ithaca, New YorkAges 18–40 - NCT07362095RecruitingPhase 1/Phase 2
Luspatercept for anemia after a stem cell transplant
This study tests a drug called luspatercept to see if it can help people who have low red blood cells (anemia) after a stem cell transplant for leukemia. It may improve your energy and reduce the need for blood transfusions.
Guangzhou, GuangdongAges 18–70 - NCT07366502Recruiting
Liposomal vs Regular Oral Iron After Sleeve Gastrectomy
This trial compares two types of oral iron supplements for people who have iron deficiency anemia after a sleeve gastrectomy. It aims to find which type is more effective at raising iron levels.
Istanbul, kadıköyAges 18–65 - NCT07356050Recruiting
Measles vaccine study for children with sickle cell disease
This study checks if the measles vaccine works well in children with sickle cell disease. It aims to help protect children with this condition from measles.
Cincinnati, OhioAges 6 months–6 years - NCT07328191Recruiting
Transfusion guided by quality of life for MDS or AML
This study is for people with MDS or AML who are not receiving treatment to cure the disease and need regular blood transfusions. It looks at whether using a quality-of-life questionnaire can guide transfusion decisions, to see if fewer transfusions can keep you feeling well.
NiceAges 18 years+ - NCT07319845RecruitingPhase 2
Study of a new drug for anemia in lower-risk myelodysplastic syndromes
This trial tests an investigational drug, TAK-226, for people with lower-risk myelodysplastic syndromes (MDS) who have anemia. The study aims to see if the drug can help improve blood counts and reduce the need for red blood cell transfusions.
Tokyo, Bunkyo-kuAges 18 years+ - NCT07315295Recruiting
Iron in therapeutic foods for malnourished kids in Kenya
This study tests whether adding extra iron to ready-to-use therapeutic foods helps malnourished children recover faster. It compares outcomes in children with severe or moderate malnutrition and healthy children.
Msambweni, Kwale CountyAges 1 year–4.5 years
Hear when a new Anemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for anemia?
- Yes. Clin2 currently lists 258 recruiting anemia studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a anemia trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a anemia trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.